Prescribing Information for:KliovanceKliofemNovofemTrisequensVagifem

Prescribing Information for:KliovanceKliofem

NovofemTrisequensVagifem

Effectively treats the root cause of vaginal atrophy1

Effectively treats the root cause of vaginal atrophy1

Effective1,2 convenient and clean3,4

Recommend Vagifem® 10µg:
• Most prescribed local treatment for vaginal atrophy in England5
• Significant improvement in vaginal health versus placebo from 2 weeks2
• Precise, user-friendly dosing delivered where it is needed1,2,6

Vaginal oestrogen is recommended by NICE for the treatment of urogenital atrophy7

References:
1. HRT preparations and equivalent alternatives https://thebms.org.uk/wp-content/uploads/2019/11/HRT-alternatives-04.11.2019.pdf (Accessed 25 June 2020). 2. Kliovance® Summary of Product Characteristics. 3. Kliofem® Summary of Product Characteristics. 4. Novofem® Summary of Product Characteristics. 5. Trisequens® Summary of Product Characteristics.

This is a Novo Nordisk® website intended for UK healthcare professionals

Date of preparation: July 2020  UK20VG00009   Privacy Policy   Contact us

This is a Novo Nordisk® website intended for healthcare professionals

Date of preparation: July 2020
UK20VG00009
Privacy Policy   Contact us